Castle Biosciences Inc SEC filings CSTL

Castle Biosciences Inc has 890 filings in SEC EDGAR's recent list, going back to Oct 2, 2008. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Castle Biosciences Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
CERT Filing Aug 17, 2026 —
8-A12B Filing Aug 14, 2026 —
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jul 30, 2026 Jul 30, 2026
8-K Current report
Shareholder vote results
May 29, 2026 May 28, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 8, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 8, 2026 —
DEF 14A Proxy statement Apr 8, 2026 May 28, 2026
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2026 Jan 11, 2026
S-8 Employee stock plan registration Nov 3, 2025 —
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 3, 2025 Nov 3, 2025
8-K Current report
Bylaw or fiscal year change
Aug 8, 2025 Aug 5, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2025 Aug 4, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
May 23, 2025 May 22, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 5, 2025 May 5, 2025
ARS Annual report to shareholders Apr 9, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 9, 2025 —
DEF 14A Proxy statement Apr 9, 2025 May 22, 2025
PRE 14A Preliminary proxy statement Mar 28, 2025 May 22, 2025
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 27, 2025 Feb 27, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 12, 2025
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2024 Aug 5, 2024
8-K Current report
Shareholder vote results
May 24, 2024 May 23, 2024
DEFA14A Additional proxy material May 10, 2024 —
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 2, 2024 May 2, 2024
EFFECT Filing Apr 16, 2024 —
CORRESP Letter to the SEC Apr 12, 2024 —
ARS Annual report to shareholders Apr 10, 2024 Apr 10, 2024
DEFA14A Additional proxy material Apr 10, 2024 —
DEF 14A Proxy statement Apr 10, 2024 Apr 10, 2024
8-K Current report
Material agreement, Officer or director change
Mar 27, 2024 Mar 26, 2024
UPLOAD Letter from the SEC Mar 7, 2024 —
S-8 Employee stock plan registration Feb 28, 2024 —
S-3 Shelf registration Feb 28, 2024 —
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 28, 2024 Feb 28, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2024 Jan 7, 2024
S-8 Employee stock plan registration Dec 4, 2023 —
8-K Current report
Officer or director change
Nov 9, 2023 Nov 3, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2023 Nov 2, 2023
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 2, 2023 Aug 2, 2023
8-K Current report
Regulation FD disclosure
Jun 5, 2023 Jun 5, 2023
8-K Current report
Shareholder vote results
Jun 1, 2023 May 25, 2023
DEFA14A Additional proxy material May 15, 2023 —
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 3, 2023 May 3, 2023
ARS Annual report to shareholders Apr 12, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 12, 2023 —
DEF 14A Proxy statement Apr 12, 2023 —
S-8 Employee stock plan registration Mar 1, 2023 —
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Feb 28, 2023 Feb 28, 2023
8-K Current report
Officer or director change
Jan 20, 2023 Jan 13, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Jan 9, 2023 Jan 8, 2023
8-K Current report
Officer or director change
Dec 28, 2022 Dec 22, 2022
8-K Current report
Officer or director change
Dec 15, 2022 Dec 9, 2022
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2022 Nov 2, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2022 Aug 8, 2022
8-K Current report
Shareholder vote results
Jun 8, 2022 Jun 2, 2022
S-3ASR Automatic shelf registration Jun 6, 2022 —
8-K Current report
Other events
Jun 3, 2022 Jun 3, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2022 May 9, 2022
8-K Current report
Unregistered share sale
May 2, 2022 Apr 26, 2022
DEFA14A Additional proxy material Apr 21, 2022 —
DEF 14A Proxy statement Apr 21, 2022 Jun 2, 2022
8-K Current report
Material agreement
Apr 7, 2022 Apr 1, 2022
8-K Current report
Material agreement, Unregistered share sale
Apr 4, 2022 Apr 4, 2022
8-K Current report
Material agreement
Mar 17, 2022 Mar 11, 2022
S-8 Employee stock plan registration Feb 28, 2022 —
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Feb 28, 2022 Feb 28, 2022
S-3ASR Automatic shelf registration Jan 14, 2022 —
8-K/A Amended current report Jan 14, 2022 Dec 2, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Officer or director change
Jan 5, 2022 Dec 29, 2021
8-K Current report
Material agreement, Acquisition or sale of assets
Dec 6, 2021 Dec 2, 2021
8-K Current report
Material agreement
Dec 3, 2021 Nov 29, 2021
10-Q Quarterly report Nov 8, 2021 Sep 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Nov 8, 2021 Nov 8, 2021
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 19, 2021 Oct 18, 2021
8-K Current report
Other events
Sep 9, 2021 Sep 9, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2021 Aug 9, 2021
8-K Current report
Officer or director change
Jul 16, 2021 Jul 14, 2021
8-K Current report
Shareholder vote results
Jun 14, 2021 Jun 10, 2021
DEFA14A Additional proxy material May 13, 2021 —
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2021 May 10, 2021
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 10, 2021
8-K Current report
Officer or director change
Apr 9, 2021 Apr 6, 2021
S-8 Employee stock plan registration Mar 11, 2021 —
10-K Annual report Mar 11, 2021 Dec 31, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Mar 8, 2021 Mar 8, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2021 Jan 13, 2021
8-K Current report
Agreement ended
Dec 22, 2020 Dec 21, 2020
8-K Current report
Other events
Dec 16, 2020 Dec 15, 2020
424B5 Prospectus supplement Dec 16, 2020 —
424B5 Prospectus supplement Dec 14, 2020 —
S-3ASR Automatic shelf registration Dec 14, 2020 —
8-K Current report
Other events
Dec 14, 2020 Dec 14, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report
Officer or director change
Aug 20, 2020 Aug 16, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
8-K Current report
Other events
Jun 30, 2020 Jun 24, 2020
424B4 Prospectus Jun 25, 2020 —
POS EX Filing Jun 25, 2020 —
EFFECT Filing Jun 24, 2020 —
S-1MEF Filing Jun 24, 2020 —
CORRESP Letter to the SEC Jun 22, 2020 —
CORRESP Letter to the SEC Jun 22, 2020 —
S-1 Registration statement Jun 22, 2020 —
UPLOAD Letter from the SEC Jun 17, 2020 —
DRS Filing Jun 12, 2020 —
8-K Current report
Shareholder vote results
Jun 9, 2020 Jun 4, 2020
8-K Current report
Officer or director change
Jun 2, 2020 May 29, 2020
8-K Current report
Officer or director change
May 28, 2020 May 21, 2020
DEFA14A Additional proxy material May 22, 2020 —
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
DEFA14A Additional proxy material Apr 23, 2020 —
DEF 14A Proxy statement Apr 23, 2020 Jun 4, 2020
8-K Current report
Regulation FD disclosure, Other events
Apr 15, 2020 Apr 15, 2020
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Apr 1, 2020 Apr 1, 2020
S-8 Employee stock plan registration Mar 10, 2020 —
10-K Annual report Mar 10, 2020 Dec 31, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Mar 10, 2020 Mar 10, 2020
8-K Current report
Material agreement
Mar 5, 2020 Feb 28, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Jan 9, 2020 Jan 9, 2020
8-K Current report
Material agreement, Officer or director change
Dec 19, 2019 Dec 13, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2019 Nov 11, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 11, 2019
10-Q Quarterly report Sep 3, 2019 Jun 30, 2019
8-K Current report
Results of operations
Sep 3, 2019 Sep 3, 2019
D Filing Jul 30, 2019 —
S-8 Employee stock plan registration Jul 29, 2019 —
8-K Current report
Unregistered share sale, Bylaw or fiscal year change, Other events
Jul 29, 2019 Jul 29, 2019
424B4 Prospectus Jul 26, 2019 —
EFFECT Filing Jul 24, 2019 —
S-1MEF Filing Jul 24, 2019 —
SEC STAFF LETTER Filing Jul 24, 2019 —
CORRESP Letter to the SEC Jul 23, 2019 —
CORRESP Letter to the SEC Jul 23, 2019 —
CERT 8a cert Jul 23, 2019 —
FWP Free writing prospectus Jul 19, 2019 —
S-1/A Amended registration statement Jul 19, 2019 —
8-A12B Filing Jul 15, 2019 —
CORRESP Letter to the SEC Jul 15, 2019 —
CORRESP Letter to the SEC Jul 15, 2019 —
S-1/A Amended registration statement Jul 15, 2019 —
CORRESP Letter to the SEC Jul 9, 2019 —
UPLOAD Letter from the SEC Jul 8, 2019 —
CORRESP Letter to the SEC Jun 26, 2019 —
S-1 Registration statement Jun 26, 2019 —
UPLOAD Letter from the SEC Jun 10, 2019 —
SEC STAFF LETTER Filing Jun 5, 2019 —
DRS Filing May 14, 2019 —
D/A Filing Mar 21, 2019 —
D Filing Feb 14, 2019 —
D Filing Jun 13, 2018 —
D Filing Jan 19, 2018 —
D Filing Jul 30, 2015 —
D Filing Aug 18, 2014 —
D Filing Aug 5, 2014 —
D Filing May 5, 2014 —
D Filing Nov 19, 2013 —
D Filing May 16, 2013 —
D Filing Oct 4, 2012 —
D Filing Mar 12, 2010 —
D/A Filing Mar 20, 2009 —
D/A Filing Mar 20, 2009 —
REGDEX Auto-generated paper document Oct 2, 2008 —

Showing 197 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
CSTL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Friendswood, TX
SEC filer status
Accelerated filer
SEC CIK
1447362

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.